论文部分内容阅读
目的选取慢性盆腔炎患者90例作为研究对象,探讨左氧氟沙星联合甲硝唑盆腔灌注深部热疗对慢性盆腔炎的临床效果。方法选取2015年12月—2016年10月平顶山市解放军第一五二中心医院收治的慢性盆腔炎患者90例作为研究对象,将所有患者随机分为观察组和对照组,每组45例。对照组采用静脉注射左氧氟沙星及甲硝唑治疗,观察组采用左氧氟沙星和甲硝唑盆腔灌注联合深部热疗治疗,两组均连续治疗3个疗程。对比两组临床疗效及不良反应发生率。结果观察组治疗总有效率为93.33%,明显高于对照组的68.89%,差异有统计学意义(P<0.05);观察组不良反应发生率为4.44%,低于对照组的17.78%,差异有统计学意义(P<0.05)。结论左氧氟沙星联合甲硝唑盆腔灌注深部热疗对慢性盆腔炎的临床效果显著,不良反应发生率低。
Objective To select 90 patients with chronic pelvic inflammatory disease as the research object to investigate the clinical effect of levofloxacin combined with metronidazole pelvic perfusion deep hyperthermia on chronic pelvic inflammatory disease. Methods 90 patients with chronic pelvic inflammatory disease admitted from the 125nd Central Hospital of Pingdingshan City from December 2015 to October 2016 were selected as the research object, all patients were randomly divided into observation group and control group, 45 cases in each group. The control group was treated with intravenous levofloxacin and metronidazole. The observation group was treated with levofloxacin and metronidazole pelvic perfusion combined with deep hyperthermia. Both groups were treated for 3 courses continuously. The clinical efficacy and incidence of adverse reactions in both groups were compared. Results The total effective rate of the observation group was 93.33%, which was significantly higher than that of the control group (68.89%), the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was 4.44%, which was lower than that of the control group (17.78% There was statistical significance (P <0.05). Conclusion Levofloxacin combined with metronidazole pelvic perfusion deep hyperthermia has a significant clinical effect on chronic pelvic inflammatory disease with a low incidence of adverse reactions.